Abbott Laboratories

Pharmaceuticals
United States
Earnings Per Share Growth (%)95.97%
Cost of Goods Sold (US$ Millions)$8,747
Current Liabilities (US$ Millions)$9,186
Total Assets (US$ Millions)$14,155
Long Term Debt$5,871
Return on Equity20.55%
Revenue (US$ Millions)$20,405
Total Company Assets$41,247
Revenue Growth (%)0.78%
Net Income (US$ Millions)$4,423
Earnings Per Share (US$)$95.97
Total Equity (US$ Millions)$21,211
Profit Margin (%)21.68%
Debt To Equity Ratio (%)0.28%
Inventory Turnover$2,599